Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study
Objective: Anticoagulation therapy, including enoxaparin, is crucial for preventing blood clots in patients at risk for thromboembolic events. However, due to enoxaparin’s enhanced renal elimination, proper prophylactic dosing may be challenging. This exploratory study evaluates antifactor Xa levels...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Seria: | Journal of Research in Pharmacy Practice |
| Hasła przedmiotowe: | |
| Dostęp online: | https://journals.lww.com/10.4103/jrpp.jrpp_11_25 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|